Don't worry bout the mule, just load the wagon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not always, sometimes an insider gets greedy and conspires with a contracted CRO. Shit happens to great tickers. Now, today, presently, I like what CytoDyn has evolved into.
How many go to the moon and stay there forever?
Even some paid bashers repent, spill the beans, and go long.
$CYDY$ 2024
but what about when you find out... and you are already invested? That was a stupid statement to make on your part of all people a moderator. But wait, then the new management and board clean house and bring you new CEO and new protocols and the lifting of holds. Sounds like the time to double down.
so why are you even here?
I am here because I like the candidate leronlimab. It is safe and has good qualities so much so it has saved people from imminent death and so much better than "trending" that got rendeathsonear approved although it was shit canned for Ebola for killing too many in China of all places!! That's ok though with you.
Don't like it when the shit comes back at ya do ya? Oh poor baby.
Must be some students of hers that hang around CytoDyn chat sites.
Can you imagine the fact checkers and other dishonesty researchers to be the real frauds!! Some are here on CYDY posing as just the facts and other shell games flung deep in the pooh.
A Harvard academic fraud case deepens
Hey readers,
Kelsey here. Last summer, I wrote about Harvard Business School professor Francesca Gino, a famous “dishonesty researcher” who was suspended from Harvard after it was revealed that someone had manipulated the data in four papers she co-authored over the course of a decade.
In response, Gino — who has maintained her innocence — sued Harvard and the bloggers who first published the allegations, claiming she’d been defamed.
I’ve written about how her lawsuit will have negative consequences for the scientific community, stifling critics and making it even less likely that research fraud, when it happens, will come to light. But there’s one respect in which the lawsuit has been enormously valuable for casting light on the allegations against Gino.
Harvard’s lengthy internal investigation of the allegations was not originally released to the public. Last week, a Massachusetts judge ordered it unsealed, granting the world a look at Harvard’s process as they investigated the possibility that one of their star researchers had fabricated her data — and a look at Gino’s defense.
Overall, the document makes the allegations of Gino’s misconduct look more warranted than ever.
But that still may not be enough to prevent an expensive legal battle. Given that it is increasingly evident that scientific fraud is nowhere near as rare as anyone hoped, we desperately need better processes for identifying it. We also need a better means of protecting the people who stick their necks out to bring it to light.
What Harvard found
The Gino saga turns on four papers — published in 2012, 2014, 2015, and 2020. In each of them, independent data detectives found telltale signs of manipulation: rows that had been altered or inserted in the data, and which conveniently produced dramatic effects supporting her hypotheses. The data detectives alerted Harvard of their concerns.
Harvard commissioned an independent investigation into the allegations. The resulting report is almost 1,300 pages — longer than Infinite Jest — though that doesn’t mean it’s dull. It details how the research team systematically determined that, for each of the four papers, the data was indeed manipulated. And it includes Gino’s theories of who did it and why.
One explanation Gino offered Harvard for the manipulated data stands out: her theory that the data was manipulated by an academic rival of Gino’s seeking to take revenge over a disagreement.
If that sounds far-fetched, well, the report’s authors agreed. The major problem is that while there are many people who could have manipulated the data for any one of the studies, the only common denominator across all of them — over eight years — was Gino.
“In order to falsify data across all four studies’ records,” the report observes, “actors with malicious intentions would have needed the following: First, they would have needed access to both Professor Gino’s Qualtrics accounts and her computer’s hard drive, as two allegations (1 and 2) involve discrepancies in Qualtrics data and one allegation (3) involves discrepancies in the computer’s data.”
Then they’d also have needed a co-conspirator in order to falsify the data associated with allegation 4. Then they’d also have needed deep familiarity with how Gino stored and labeled data on her computer and her planned timetable for each study, just to maliciously alter the study to make her look bad.
Then, having carefully engineered this evidence of data misconduct, they would need to sit still for years before revealing the evidence of falsification.
It’s a stretch, to put it mildly.
Could this possibly be defamation?
“Defamation,” defamation lawyer Ken White told me last summer, “is an unprivileged false factual statement about someone which causes harm. Where a lot of the action comes in is determining what is a provably false factual statement.”
The Harvard report makes it abundantly clear that Gino will have an uphill battle convincing any court that the Data Colada bloggers made a provably false factual statement. For one thing, the data was clearly manipulated.
So far, her primary argument for why she didn’t commit fraud is, basically, that maybe she was carefully and elaborately framed for it by someone with access to her computer and her logins over the course of eight years.
That’s a fundamentally unserious theory of this situation, and Harvard’s analysis commission was correct to conclude it was highly unlikely. The only reason we’re obliged to take it seriously is that Gino’s lawsuit is a serious matter, whether the underlying claims are reasonable or unreasonable.
“The system is so broken that being sued for defamation in a case like this will cost hundreds of thousands of dollars and go on for years,” White told me earlier. “Realistically, you could wind up going to trial. Even if you’re going to win at trial, eventually you’re going to be ruined doing it.”
Gino doesn’t need to win her lawsuit to have a devastatingly chilling effect on independent experts searching for fraud. She doesn’t even need to propose a credible theory of how the data manipulation could have happened without her involvement. It doesn’t matter if her explanation strains credulity. “The process is the punishment,” as White put it.
That’s a huge problem because scientific fraud is a huge problem. Between the dishonesty researchers who have one by one turned out to be dishonest and the cancer research that turned out to be reusing Photoshopped versions of the same test result pictures, the last few years have been full of discomfiting reminders that, yes, some people will cheat to get ahead in science, and we lack a robust process for catching them.
Scientific integrity currently depends on the willingness of individuals to speak out when they see fraud, and it’s precisely that willingness Gino’s lawsuit targets.
—Kelsey Piper, senior writer
I vote Kelsey Piper for Cytodyn communications director. $CYDY$ 2024
You seem so much more desperate than before since your last bashing and attempt at mischaracterizing. Sharpen up my little leperCon
It's been pointed out many times. Go and find it.
I agree but I also am thinking beyond NASA. Many small accounts would suit me fine until a big one comes. There is danger with all the eggs in one basket.
At what point will you ever tell the truth?
Lesson #1. Don't buy Pfizer after the govt uses your taxpayer money to support the sale of phony vaccines that the world had moslty turned away from. Just look at their sales! DOWN hard. PPS tubed. Sorry for your Pfizer loss. LMAO
A big weekend AMEN to that post misiu143.
Bingo
$CYDY$ 2024
Sure hope the Fed does their job right. Too many cases lately where the blind lady turned to look the other way.
This is better than any soap opera. "As The Pharma World Turns" would be a great mini series!
Wherever it be, let it be the truth.
$CYDY$
Sidley must be getting an earful. You go girl.
Yes, in the early days. He fooled us all just like Fauci, Redfield and ScarfLady. And now look who got the Noble!! LMAO.
Were the FDA not so implicit with the Covid game, we would have had EUA and then later full approval.
Nevertheless, Nada was the lesser of the two evils. 13D had fooled a lot of investors, thankfully enough had common sense to make the right choice.
The world is not always easy and tough choices must be made. The company made the right choice and canned the CEO because of some very stout investors who believe resolutely in leronlimab which is why $CYDY$ 2024. Go Dr. J
I am well educated. But it only takes what most leronlimab bashers seem to not have...common sense.
Covid scam is why many companies other than CytoDyn ran into a brick wall.
On top of that, who would ever be afraid what the most imminent scientist and medical researchers
are saying, or have said, and now why many are just keeping quiet? Wonder what Pourhassan is saying behind closed door?
Have bashers read their medical studies and not reached the conclusion that what they demonstrate is quite compelling? Investors and the public cannot just rely on what the status quo controlled response has been. How about some foreign governments that reversed
their covid policies? Take leronlimab, it was doing quite well saving life in the Philippines. Pig Pharma could not handle the successes. How about the courts around the world that have thrown out mandatory
draculean orders as contrary to free will? What would they have done had they known about leronlimab? How about all the lies of Fauci et al, and all the hiding
of data and changing of data within the cdc and fda? He knew about leronlimab even remarking once about it. How about the Chinese bat lady who worked in the Chinese lab??? I want to know if she worked ...before her death.. on the Chinese RENDESIVIR study that was canceled because too many subjects died or suffered horribly?? Not good enough for Ebola but good enough for COVID!! And leronlimab could not even get EUA!! Not ivermectin nor HCQ and a few other mabs. SEE ANYTHING WRONG IN THIS SCENE?
How come there have been more deaths and adverse reactions from the Covid vaccines than all other vaccines combined in history? And the FDA could have acted responsibly and at least given leronlimab a go. They knew it was safe, and they knew it showed much promise because of the years of studies with HIV. Why do paid bashers support this behaviour? No one is that blind, rather they are dishonest and corrupt.
https://vigilantfox.news/p/dr-mccullough-testifies-the-
Real researchers or investigators, you would want to pay close attention to all sides. Curiosity alone should make one wonder why there is such an outcry worldwide that does not agree with the mRna vaccines as beneficial. Do deniers not scratch their head and wonder too? Wouldn't all want to know what the heck is going on?
So in closing here for the weekend, we must all wonder and feel something is astray when so many prominent medical scientists and professors have lost their jobs over questioning the official doctrine? Is this why truth deniers don't support what works like the doctors using time tested protocols and drugs that got Right To Try like LERONLIMAB where life was saved! Why so many other health professionals with their own protocols have had much better results than using the "vaccines"?
https://www.theguardian.com/world/2021/oct/13/scientists-abused-and-threatened-for-discussing-covid-global-survey-finds
What the world needs is more open dialogue and the opportunity to express freely without fear of retribution. We live in really sad precarious times when the voice of reason is muted. I thought investigators kept an open mind? Leronlimab is under investigation, so let's give it a try.
$CYDY$ 2024
These short paid bashers have their head buried where the sun doesn't shine.
The lack of Vit.D is telling.
Leronlimab is safe. And thus far looks quite compellingly effective which is why the huge numbers of investors still support the company despite the
13D takeover attempt that everyone saw through. It was much better to support the company even with Pourhassan than give it away to scoundrels
that would have given it away in turn.
These short paid bashers fool no one except maybe a dizzy one or a leperCon.
$CYDY$ 2024 Leronlimab, we got it, they want it. They will pay for it, on our terms. Dig deep.
What lies liar?
Did you forget the studies that demonstrated it's safety... and effectiveness? Did you notice the shift in attitude at the FDA? Did you notice that fanny slap they gave to AmarX?
We note too that AmarX is responsible once that CEO conspired with Pourhassan. Ooopsie
Going to be a nice payday. Get ready.
$CYDY$ 2024
Only weird to you. The liar that you are as everyone knows for all these years on Ihub.
The only one that believes you are short paid bashers. Why is that?
On all your posts everywhere it is the same.
Let me know when you want some trading lessons.
1. I believe in leronlimab
2. I like Dr. J
3. I like that the hold was lifted...all of them
4. I like SIDLEY
5. I like the huge investor list
6. I like the fact that the bashers give us the opportunity to make the green bags bigger
$CYDY$ Go Dr. J, Go Sidley, and a big thanks to the FDA for working with us on the protocol which we should be hearing about ......soon!
No brainer. After the addition of the domestic mgf. most likely they have other announcements coming fairly soon. Nobody adds a mgf. facility to let it remain idle.
Hey Emmett Kelly, do you think the company doing claim improvements and development work which involves sampling using various techniques can be done without a permit? Are you saying they are proving up the minerals without permits to do so????? How many claims have you worked on?
You are posting lies. Good luck with your paid bashing or are you just short a tad and trying to protect that position?
Well, news for you. The pps will surge as the company continues making headway.
The original answer to your worthless post was not concerning financials but permits. Get it?
Now in addition should you read what myself and others have posted about mining companies
you would not be so ignorant in your replies even as to revenue from production. Do you have an
inkling of a guess what that would entail? Or like a typical basher, prefer to dodge, shuck, and jive?
Why, could it be because Diane Feinstein is the legislative support and they want to keep the lid on things while they fill their mugs with liquid metal?
Boeing sure needs some help. Liquid Metal to the rescue? Boeing AeroSpace? Time for shoddy parts replacement.
If they do 1/10 of the projected growth I will be elated. This may well set some records.
Yeah right. How about learning to read and respond if you must to what was written.
F-, repeat the 1st grade.
Because leronlimab works and is safe.
$CYDY$ 2024
Sacre Couer mon ami!!! Excellente
LOL, I like your style!!
Bashers are a traders best friend. They provide me with lots of cheapies to cash in on the upswings which I in turn invest into those that have some solid fundamentals and are at a bargain due to shorting or due to technical traders taking profit.
Thanks for the cheapies pigeons, as always this will go back up.
Looking for a nice surge when new protocol is enacted.
$CYDY$ Good job thus far DR. J. Keep it coming. 2024
That seems good although I do not trust this AI ChatGPT yet. Just as I don't trust what I cannot see like Q. Just like I don't trust many posters. I don't distrust them either as long as they are concentrated on the pros and cons of the stock. I reserve judgement and just because I disagree doesn't equate to like or dislike.
The company has valuable minerals in the ground. They will most likely continue to prove up the values in order to sell out, or trade up or partner. That's the general idea. Most of these development mining companies do not progress to mining. Like in real estate, there are different stages of ownership. There are also the scammers as we all know. As an older owner Perry would have scammed out long ago, not taken the property to the grave. He didn't need the money. He was a real prospector as only prospectors can really understand. So looking forward, it appears to be headed in the right direction.
wrong. Here, learn something. https://mining.ca/resources/reports/project-permitting-in-canada-and-the-mining-industry/
There would be no sampling on any kind without the development permits needed to proceed. You have posted this nonsense before
and you know better but continue anyway. Why is that? Loading up?
The troll idiot rides again making up lies when his ass gets burned.
LMAO, what a piece of work.
Only a trolling idiot who doesn't trade would say something so stupid as your reply.
1. Check the historical chart
2. Check again the reference was to how I trade bottom dwellers in general.
3. Try doing some trading. You may learn something like how price movement
means Up and Down. Why some thinly traded make huge moves! Most of these
OTC babies go from thinly traded to heavily traded and back again. A few actually
make it to the big leagues.
4. Assumptions are a self killer. You assume there is no future which indicates
your lack of experience and knowledge in the land of pennies where you spend
all your time screwing around sniffing butts.
5. Minerals in the ground are in the safest bank in the world. Think.
LOL, cat got your tongue?
Stop this idiotic drizzle. Does anyone mention all their goings on in the investment world?
Certainly not you. You don't seem to own anything according to this analogy except your
huge dividends on the loser Fizzled Fizer. LMAO
"You've never mentioned it before YESTERDAY....anywhere on IHUB"
Inspecteur CloseOut rides again!
Actinium Pharmaceuticals Inc (ATNM) 06/04/2020 02:21:05 PM 2 Posts
$CYDY$ 2024
Show proof... to you? Like I told the leperCon many times, I only post on a very few of my holdings which runs up and down from 50 or so to about 80.
LeperCon only posts about other people, too chicken shit to venture to say anything regarding fundamentals.
So now let's don't dance away from the original meaning of the post. You love to two-step away.
Actinium is pre-rev OTC with falling financials yet going UP UP UP. Wow, think of it. How could that be Monsieur Inspecteur?
So at least you admitted your mistake...think I will book mark it!!
Geeze fungicide, been in it for a long time! This is what I do. It's called "timing". Try it.
LOL, How do you know??? Only idiot pigeons gravel on pebbles.
You must have overlooked Actinium Pharma. Would be a great company to collaborate with in regards to their pipeline.
Case in point ATNM is pre revenue with slumping financials yet slated to go up from $20 to $50 pretty soon as Ph3 trial almost at a close.
Doubled my money in it yesterday.
As usual, the Lepper Con is all about BS and lies.
HIV Gene Therapy Clinical Trials Based on In Vivo Delivery
Studies employing the in vivo approach in HIV are mainly at the pre-clinical stage. In vivo approaches involve the introduction of the gene therapy product directly to the patient using either viral vectors like adenoviral vectors, adeno-associated virus vectors or non-integrating lentiviral vectors, or through non-viral methods like nanoparticles. In vivo methods may not provide a long-lasting cure, because there is no stable integration of the transgene with the host’s genetic material, and the delivery to specific cells needs to be optimised to reduce the chances of off-target effects. Gene editing through recombinase or nuclease systems [61], or silencing mechanisms using RNA interference or possibly CRISPR-interference, could use the in vivo approach.
Current clinical trials include a study that used leronlimab, an anti-CCR5 humanized IgG4 antibody that competitively inhibits HIV env attachment to CCR5 by binding to the same attachment site as CCR5 (the extracellular loop-2 and N-terminus domains). This agent was administered subcutaneously, and the group is currently working on using a synthetic AAV vector for delivery. Several versions of this study—NCT00642707, NCT02175680, NCT02355184, NCT02483078, NCT02990858, NCT03902522, NCT02859961 and NCT05271370— demonstrated the safety and efficacy of the product, with patients experiencing mostly mild side effects and efficacy being observed at higher doses of 525 mg and 700 mg [221].
Advances in HIV Gene Therapy
by Rose Kitawi 1, Scott Ledger 1, Anthony D. Kelleher 1,2,3 and Chantelle L. Ahlenstiel 1,3,* [ORCID]
1
Kirby Institute, University of New South Wales, Kensington, NSW 2052, Australia
2
St. Vincent’s Hospital, Darlinghurst, NSW 2010, Australia
3
UNSW RNA Institute, University of New South Wales, Kensington, NSW 2052, Australia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(5), 2771; https://doi.org/10.3390/ijms25052771
Submission received: 2 November 2023 / Revised: 20 February 2024 / Accepted: 20 February 2024 / Published: 28 February 2024
(This article belongs to the Special Issue Advances in Gene and Cell Therapy 2.0)
Abstract
Early gene therapy studies held great promise for the cure of heritable diseases, but the occurrence of various genotoxic events led to a pause in clinical trials and a more guarded approach to progress. Recent advances in genetic engineering technologies have reignited interest, leading to the approval of the first gene therapy product targeting genetic mutations in 2017. Gene therapy (GT) can be delivered either in vivo or ex vivo. An ex vivo approach to gene therapy is advantageous, as it allows for the characterization of the gene-modified cells and the selection of desired properties before patient administration. Autologous cells can also be used during this process which eliminates the possibility of immune rejection. This review highlights the various stages of ex vivo gene therapy, current research developments that have increased the efficiency and safety of this process, and a comprehensive summary of Human Immunodeficiency Virus (HIV) gene therapy studies, the majority of which have employed the ex vivo approach.
Loser, knew your written word was worthless.
Go look up restitution, go read the red print and
the cases cited.
$CYDY$ 2024
Lost the grip on those reading glasses appears again R.I.P ?
Admit it, pigeons don't like to drink leronlimab no matter how safe or
effective, nor ivermectin, nor HCQ. Interesting perplexity. Are they even
human? NO! They are pigeons and a leper con. So they battle for a few
pennies over whether or not leronlimab is safe and effective.
Short bashers are great at selective reading. Even then, the problem is
acknowledging they got a problem. Kind of like those who are hollering
conspiracy when all thousands of doctors and scientists who say BS to
the CDC and FDA. Even as the numbers don't lie with dead celebrities
in the news daily keeling over from one secondary Covid problem or the
other 750 side effects recorded. But oh no, let's get in line for the Kraken!!
Belly on up to the jab bar boys and girls.